SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-012814
Filing Date
2023-08-02
Accepted
2023-08-02 08:30:38
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20230630x10q.htm   iXBRL 10-Q 1230482
2 EX-10.1 glyc-20230630xex10d1.htm EX-10.1 19309
3 EX-31.1 glyc-20230630xex31d1.htm EX-31.1 16951
4 EX-31.2 glyc-20230630xex31d2.htm EX-31.2 16767
5 EX-32.1 glyc-20230630xex32d1.htm EX-32.1 9430
  Complete submission text file 0001558370-23-012814.txt   5244083

Data Files

Seq Description Document Type Size
6 EX-101.SCH glyc-20230630.xsd EX-101.SCH 33980
7 EX-101.CAL glyc-20230630_cal.xml EX-101.CAL 34842
8 EX-101.DEF glyc-20230630_def.xml EX-101.DEF 162954
9 EX-101.LAB glyc-20230630_lab.xml EX-101.LAB 346782
10 EX-101.PRE glyc-20230630_pre.xml EX-101.PRE 281459
53 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20230630x10q_htm.xml XML 834318
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 231133831
SIC: 2834 Pharmaceutical Preparations